Cargando…
Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
BACKGROUND: Cardiovascular disease is the leading cause of death and disability worldwide. Therefore, as part of the Dyslipidemia International Study (DYSIS), we have analyzed the prevalence of lipid abnormalities and risk factors for dyslipidemia in statin-treated patients in Lebanon and Jordan. ME...
Autores principales: | Azar, Sami T, Hantash, Hadi Abu, Jambart, Selim, El-Zaheri, Mohamed M, Rachoin, Rachoin, Chalfoun, Amal, Lahoud, Layla, Okkeh, Osama, Bramlage, Peter, Brudi, Philippe, Ambegaonkar, Baishali M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025935/ https://www.ncbi.nlm.nih.gov/pubmed/24872710 http://dx.doi.org/10.2147/VHRM.S57194 |
Ejemplares similares
-
Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
por: Al Sifri, Saud N., et al.
Publicado: (2014) -
Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
por: Liberopoulos, Evangelos, et al.
Publicado: (2018) -
Mixed dyslipidemias in primary care patients in France
por: Laforest, Laurent, et al.
Publicado: (2012) -
Do acute coronary events affect lipid management and cholesterol goal attainment in Germany?: Results from the Dyslipidemia International study II
por: Gitt, Anselm K., et al.
Publicado: (2018) -
The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)